Ventana Medical Systems
Chad Wilkinson is an experienced professional in the field of research and development, currently serving as R&D Senior Manager for Companion Diagnostics (CDx) at Ventana Medical Systems since February 2021. Previously, Chad held the position of Principal Systems Engineer at Roche Sequencing USA from May 2015 to February 2021, and spent over 14 years at Ventana Medical Systems in various roles including Staff Scientist, Senior Scientist, Development Scientist, and Research and Development Associate. Chad holds a Master's degree in Applied Biosciences and a Bachelor of Science in Physiology from the University of Arizona.
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.